TABLE 4

Biodistribution of 99mTc-EC20

OrganSubcutaneous tumorIntraperitoneal tumor*
Intravenous doseIntraperitoneal doseIntravenous doseIntraperitoneal dose
Blood0.26 ± 0.070.28 ± 0.060.38 ± 0.230.18 ± 0.02
Heart2.20 ± 0.062.62 ± 0.501.34 ± 0.351.75 ± 0.42
Lung1.58 ± 0.192.25 ± 0.371.46 ± 1.141.20 ± 0.13
Liver4.22 ± 0.044.29 ± 0.714.67 ± 1.423.19 ± 0.15
Intestine3.04 ± 2.042.64 ± 1.263.10 ± 2.242.77 ± 1.66
Kidney109.90 ± 12.898.78 ± 6.9125.96 ± 15.5105.65 ± 11.1
Muscle1.99 ± 0.391.90 ± 0.321.79 ± 0.801.39 ± 0.57
Spleen0.44 ± 0.070.51 ± 0.131.81 ± 1.760.69 ± 0.15
Tumor17.24 ± 4.2218.77 ± 5.1217.07 ± 3.3916.24 ± 1.32
Stomach1.43 ± 0.071.48 ± 0.121.49 ± 1.461.83 ± 0.88
  • * Each intraperitoneal tumor is sum of 4–6 tumor nodules (30–60 mg each).

  • BALB/c mice (weight, 20 ± 2 g) bearing subcutaneous or intraperitoneal tumors were injected intravenously or intraperitoneally with 99mTc-EC20 and then necropsied after 4 h. Values are the means ± SD (n = 3).